Company Profile:

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. It was founded in 1849 and is headquartered in New York, New York.

Recent News:

On May 18, 2020, the company announced the pricing of $4,000,000,000 Debt Offering. Pfizer intends to use the net proceeds for general corporate purposes, including to repay a portion of its outstanding commercial paper and/or to refinance, redeem or repurchase existing debt.

On May 14, 2020, the company announced Ppositive top-line results from phase 3 lot consistency study of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.

Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.

@@@@@

Profitability – Measures the historical price movement of the stock.

@@@@@

Solvency – Measures the solvency of the company based on several ratios.

@@@@@

Efficiency – Measures the strength and historic growth of a company’s return on invested capital.

@@@@@

Conclusion:

PFE’s strengths can be seen in its better efficiency compared with its peers. Technical indicators signal the bullish signs, as there is a bullish crossover in Stochastic oscillator, MACD is trying to cross back up and the RSI stands at 58.11 with positive bias. We rate Pfizer Inc (PFE) a STRONG BUY.